A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...

For patients with IIH, sustainable weight loss offers the most effective and lasting relief from symptoms—and can help ...

A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and ...

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...

Novo Nordisk said on Monday it would halt its collaboration with U.S. telehealth company Hims & Hers Health over the ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Prescriptions for Mounjaro jabs, to help people lose weight, will be available at GP surgeries in England from today - but ...

People started on a low dose of Amgen's long-acting experimental obesity drug MariTide lost as much weight as those given ...

Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls its ...

Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while ...

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

Infection, delayed kidney function, kidney loss and death are all risks associated with kidney transplant surgery in obese ...